Biocartis Group NV: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test

    NEXT STORY
    Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2018 Results; Announces Changes to Senior Leadership
    PREV STORY
    Terveystalo Plc: Report by the Board of Directors, Financial Statements and Corporate Governance Statement 2018 published
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

    CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News

    Geron Provides Imetelstat Program Update

    author_avatar
    NASDAQ Market News

    Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease

    BOSTON, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that ...

    author_avatar
    NASDAQ Market News